Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
About 10 fewer cases of acute urinary retention and surgery per 1000 patient-years of treatment . . . but about 30 treatment withdrawals due to sexual disorders.
D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D018120:Finasteride / Q000009:adverse effects / Q000627:therapeutic use*; D005602:France; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D012725:Sexual Behavior / Q000187:drug effects / Q000502:physiology; D016055:Urinary Retention / Q000209:etiology / Q000517:prevention & control
D004791:Enzyme Inhibitors; D018120:Finasteride